510(k) · Cleared
ClearedIcobrain
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Icometrix NV · LLZ System, Image Processing, Radiological
Cleared on Dec 13, 2019 as substantially equivalent to K181939 (Icometrix NV, 2018) after a 128-day review. Its family tree reaches back 4 generations to 2006. 3 later devices descend from it.
- Decided
- Dec 13, 2019
- Review
- 128 days
- Class
- Class II
- Product code
- LLZ
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to K061855 (2006). 3 later devices descend from it, 3 citing it directly.
- Root · 4 generations backK061855 NeuroquantCortechs Labs, Inc. · 2006
- 3 generations backK161148 icobrainIcometrix · 2016
- 2 generations backK180326 icobrainIcometrix · 2018
- 1 generation backK181939 icobrainIcometrix NV · 2018
- This deviceK192130 IcobrainIcometrix NV · 2019
- Descendant · cites it directly · 0 of its ownK231929 iQ-solutionsSydney Neuroimaging Analysis Centre Pty, Ltd. · 2023
- Descendant · cites it directly · 0 of its ownK223659 JazzAi Medical AG · 2023
- Descendant · cites it directly · 0 of its ownK223180 AIRAscoreAiramed GmbH · 2023
Most influential descendants
Showing 3 of 3 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K061855 | Neuroquant | Cortechs Labs, Inc. | 2006 | — |
| −3 | K161148 | icobrain | Icometrix | 2016 | — |
| −2 | K180326 | icobrain | Icometrix | 2018 | — |
| −1 | K181939 | icobrain | Icometrix NV | 2018 | — |
| 0 (this device) | K192130 | Icobrain | Icometrix NV | 2019 | — |
| +1 | K231929 | iQ-solutions | Sydney Neuroimaging Analysis Centre Pty, Ltd. | 2023 | — |
| +1 | K223659 | Jazz | Ai Medical AG | 2023 | — |
| +1 | K223180 | AIRAscore | Airamed GmbH | 2023 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LLZ device
- #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K181939 | icobrainSummary page 6…2/8 6.3 Predicate Device Device icobrain 510(k) Number K181939 Manufacturer icometrix NV Common Name: Medical Image Processing… | 2018 |
What descends from it? (3)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 1.6 years on median.
- None of the 4 ancestors has a recall.
- Of its descendants, K231929 (Sydney Neuroimaging Analysis Centre Pty, Ltd., 2023) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K181939.
How does its category compare?
All LLZ devicesLLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.
FDA decisions per year · LLZ
58in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LLZ
173in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LLZ
11in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LLZ
116in 2025
MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 76 | 36 | 20 | 152 |
| 2008 | 94 | 52 | 32 | 154 |
| 2009 | 70 | 62 | 21 | 145 |
| 2010 | 51 | 98 | 17 | 145 |
| 2011 | 106 | 79 | 30 | 454 |
| 2012 | 82 | 87 | 12 | 266 |
| 2013 | 95 | 84 | 64 | 1,130 |
| 2014 | 78 | 89 | 6 | 15,631 |
| 2015 | 64 | 90 | 16 | 211 |
| 2016 | 82 | 90 | 12 | 290 |
| 2017 | 78 | 107 | 5 | 104 |
| 2018 | 104 | 105 | 7 | 72 |
| 2019 | 74 | 107 | 2 | 88 |
| 2020 | 81 | 115 | 6 | 82 |
| 2021 | 83 | 116 | 3 | 70 |
| 2022 | 65 | 137 | 4 | 28 |
| 2023 | 87 | 157 | 8 | 26 |
| 2024 | 62 | 131 | 6 | 42 |
| 2025 | 58 | 173 | 11 | 116 |
| 2026 | 45 | 110 | 14 | — |
What is it indicated for?
icobrain is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR or NCCT images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR or NCCT images. icobrain consists of two distinct image processing pipelines: icobrain cross and icobrain long. icobrain cross is intended…
Read the full statement (128 words)
icobrain is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR or NCCT images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR or NCCT images.
icobrain consists of two distinct image processing pipelines: icobrain cross and icobrain long.
icobrain cross is intended to provide volumes from MR or NCCT images acquired at a single time point.
icobrain long is intended to provide changes in volumes between two MR images that were acquired on the same scanner, with the same image acquisition protocol and with same contrast at two different timepoints.
The results of icobrain cross cannot be compared with the results of icobrain long.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K192130 · printed Nov 6, 2026
Cite this page
510(k) Report. “K192130: Icobrain.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K192130
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026